Related Experiment Video
Updated: Apr 30, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Association between serum 25-hydroxyvitamin D levels and TTN
Capan Konca1, Zelal Kahramaner, Mehmet Bulbul
1Department of Pediatrics, Neonatology Clinic, Adiyaman University, School of Medicine, Adiyaman, Turkey.
Insights
Lower serum 25-hydroxyvitamin D (25(OH)D3) levels are linked to an increased risk of transient tachypnea of the newborn (TTN). Vitamin D may play a role in TTN development.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Endocrinology
Background:
- Transient tachypnea of the newborn (TTN) is a common respiratory disorder in neonates.
- Vitamin D deficiency is prevalent globally and has been implicated in various health outcomes.
Purpose of the Study:
- To examine the relationship between serum 25-hydroxyvitamin D (25(OH)D3) levels and the incidence of TTN.
- To explore potential roles of vitamin D in the pathophysiology of TTN.
Main Methods:
- Serum levels of 25(OH)D3, calcium, phosphorus, alkaline phosphatase, and parathormone were measured in infants with TTN and healthy controls.
- Demographic data and details on vitamin D supplementation during pregnancy were collected.
Main Results:
- Infants with TTN exhibited significantly lower serum 25(OH)D3 levels compared to controls.
- Elevated parathormone levels were observed in the TTN group, with no significant differences in calcium, phosphorus, or alkaline phosphatase.
- Maternal vitamin D supplementation did not influence neonatal serum 25(OH)D3 levels.
Conclusions:
- Lower serum 25(OH)D3 levels are associated with an increased risk of TTN.
- Findings suggest a potential role for vitamin D in the pathogenesis of TTN.
Aim:
To investigate the association between serum 25-hydroxyvitamin D (25(OH)D3) levels and transient tachypnea of the newborn (TTN).
Methods:
Calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), parathormone (PTH) and serum 25(OH)D3 levels were measured in 51 infants diagnosed with TTN and 59 healthy control infants for comparison. Demographic factors including gestational age, birth weight, gender, delivery mode, parity, vitamin D supplementation during pregnancy and severity of TTN were recorded.
Results:
The serum levels of 25(OH)D3 were significantly lower in infants with TTN compared to infants with no respiratory distress (p < 0.01). There was no statistically significant difference in serum Ca, P and ALP levels between the groups while the serum levels of PTH were significantly higher in the study group (p < 0.01). No correlation was found between the serum 25(OH)D3 levels and severity of TTN. Vitamin D supplementation (400 IU/day) during pregnancy did not affect the serum levels of newborns.
Conclusion:
Our data suggests that lower 25(OH)D3 serum levels are associated with an increased risk of TTN and vitamin D may have a role in the pathogenesis of TTN.
More Related Videos
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Therapeutic Drug Monitoring: Affecting Factors
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

